BACKGROUND: Oxidative stress plays an important role in the pathobiology of exfoliation syndrome (XFS) and exfoliative glaucoma (XFG). METHODS: We investigated the prooxidant-antioxidant balance (PAB) in aqueous humour and serum samples of 20 consecutive cases of XFS, 20 of XFG, and 20 age-matched controls, employing a recently described novel assay. The activity of catalase and the levels of (hydrogen) peroxide were also measured in these samples. RESULTS: There was no significant difference between the PAB in the aqueous humour of the XFS group (82.5 +/- 10 AU) and age-matched control patients (78.9 +/- 13.4 AU; p > 0.05). A significant shift of the PAB balance in favour of oxidants was detected in the XFG group (90.2 +/- 7.6 AU) compared with controls (p < 0.001). In the serum of patients with XFS (138.8 +/- 13.2 AU) and XFG (124.08 +/- 13.50 AU), PAB was significantly altered in favour of oxidants as compared to age-matched controls (114.9 +/- 9.91 AU); p < 0.001). Catalase activity in the aqueous from XFS (10.1 +/- 4.5 U/ml) and XFG (12.2 +/- 6 U/ml) patients was significantly lower than that measured in the normal aqueous (14.6 +/- 1.9 U/ml). Similarly, a significantly lower catalase activity was found in XFS (103 +/- 21.4 U/ml) and XFG (116 +/- 38 U/ml) serum samples compared with controls (189.6 +/- 84.3 U/ml). Finally, (hydrogen) peroxide concentration in aqueous and serum samples from patients with XFS (aqueous: 26.9 +/- 6.6 microM; serum: 41 +/- 10 microM) and XFG (aqueous: 21.7 +/- 7 microM; serum: 32 +/- 4 microM) were significantly higher than that of the controls (aqueous: 9.6 +/- 5.8 microM; serum: 24 +/- 9 microM; p < 0.001). CONCLUSIONS: These findings suggest that in XFS oxidative stress is counterbalanced in the aqueous, whereas the development of XFG is accompanied by a disruption of this balance in favour of oxidants.
BACKGROUND: Oxidative stress plays an important role in the pathobiology of exfoliation syndrome (XFS) and exfoliative glaucoma (XFG). METHODS: We investigated the prooxidant-antioxidant balance (PAB) in aqueous humour and serum samples of 20 consecutive cases of XFS, 20 of XFG, and 20 age-matched controls, employing a recently described novel assay. The activity of catalase and the levels of (hydrogen) peroxide were also measured in these samples. RESULTS: There was no significant difference between the PAB in the aqueous humour of the XFS group (82.5 +/- 10 AU) and age-matched control patients (78.9 +/- 13.4 AU; p > 0.05). A significant shift of the PAB balance in favour of oxidants was detected in the XFG group (90.2 +/- 7.6 AU) compared with controls (p < 0.001). In the serum of patients with XFS (138.8 +/- 13.2 AU) and XFG (124.08 +/- 13.50 AU), PAB was significantly altered in favour of oxidants as compared to age-matched controls (114.9 +/- 9.91 AU); p < 0.001). Catalase activity in the aqueous from XFS (10.1 +/- 4.5 U/ml) and XFG (12.2 +/- 6 U/ml) patients was significantly lower than that measured in the normal aqueous (14.6 +/- 1.9 U/ml). Similarly, a significantly lower catalase activity was found in XFS (103 +/- 21.4 U/ml) and XFG (116 +/- 38 U/ml) serum samples compared with controls (189.6 +/- 84.3 U/ml). Finally, (hydrogen) peroxide concentration in aqueous and serum samples from patients with XFS (aqueous: 26.9 +/- 6.6 microM; serum: 41 +/- 10 microM) and XFG (aqueous: 21.7 +/- 7 microM; serum: 32 +/- 4 microM) were significantly higher than that of the controls (aqueous: 9.6 +/- 5.8 microM; serum: 24 +/- 9 microM; p < 0.001). CONCLUSIONS: These findings suggest that in XFS oxidative stress is counterbalanced in the aqueous, whereas the development of XFG is accompanied by a disruption of this balance in favour of oxidants.
Authors: G G Koliakos; A G P Konstas; U Schlötzer-Schrehardt; G Hollo; I E Katsimbris; N Georgiadis; R Ritch Journal: Br J Ophthalmol Date: 2003-03 Impact factor: 4.638
Authors: Matthias Zenkel; Friedrich E Kruse; Gottfried O H Naumann; Ursula Schlötzer-Schrehardt Journal: Invest Ophthalmol Vis Sci Date: 2007-12 Impact factor: 4.799
Authors: Seyyed M R Parizadeh; Mahmoud R Azarpazhooh; Mohsen Moohebati; Mohsen Nematy; Majid Ghayour-Mobarhan; Shima Tavallaie; Amir A Rahsepar; Maral Amini; Amirhossein Sahebkar; Maryam Mohammadi; Gordon A A Ferns Journal: Lipids Date: 2011-01-05 Impact factor: 1.880
Authors: Colleen M Trantow; Adam Hedberg-Buenz; Sachiyo Iwashita; Steven A Moore; Michael G Anderson Journal: PLoS Genet Date: 2010-07-01 Impact factor: 5.917